Organic Process Development
»
Обсуждения
The US FDA has issued full approval for Israeli drugmaker Teva’s Synribo (omacetaxine mepesuccinate)高三尖杉酯碱 for chronic myeloid leukaemia (CML).
фев 18, 2014 | 16:02
